IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Birchview Capital, LP

Q1 2019 Holdings

Filed 2019-05-03 | 54 holdings | $1.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Cytokinetics Inc(CYTK)COM23282W605$81.0K10,0004.4%
Arvinas Inc(ARVN)COM04335A105$443.0K30,00023.8%
Corcept Therapeutics Inc(CORT)COM218352102$587.0K50,00031.6%
Biogen Inc(BIIB)COM09062X103$591.0K2,50031.8%
PreviousPage 2 of 2